Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Feb 14;24(1):75.
doi: 10.1186/s12933-025-02637-4.

Association between the GMI/HbA1c ratio and preclinical carotid atherosclerosis in type 1 diabetes: impact of the fast-glycator phenotype across age groups

Affiliations
Multicenter Study

Association between the GMI/HbA1c ratio and preclinical carotid atherosclerosis in type 1 diabetes: impact of the fast-glycator phenotype across age groups

Carlos Puig-Jové et al. Cardiovasc Diabetol. .

Abstract

Background: Since the arrival of continuous glucose monitoring (CGM), the relationship between the glucose management indicator (GMI) and HbA1c has been a topic of considerable interest in diabetes research. This study aims to explore the association between the GMI/HbA1c ratio and the presence of preclinical carotid atherosclerosis in type 1 diabetes (T1D).

Methods: Individuals with T1D and no prior history of cardiovascular disease were recruited from two centers. Carotid ultrasonography was performed using a standardized protocol and carotid plaques were defined as intima-media thickness ≥ 1.5 mm. CGM-derived data were collected from a 14-day report. A GMI/HbA1c ratio < 0.90 was selected to identify "fast-glycator" phenotype.

Results: A total of 584 participants were included (319 women, 54.6%), with a mean age of 48.8 ± 10.7 years and a mean diabetes duration of 27.5 ± 11.4 years. Carotid plaques were present in 231 subjects (39.6%). Approximately 43.7% and 13.4% of participants showed absolute differences of ≥ 0.5 and ≥ 1.0 between 14-day GMI and HbA1c, respectively. Among patients ≥ 48 years, the fast-glycator phenotype was independently associated with presence of plaques (OR 2.27, 95%CI: 1.06-4.87), even after adjusting for non-specific and T1D-specific risk factors and statin treatment. No significant association was observed in younger subjects (p for interaction < 0.05).

Conclusions: Fast-glycator phenotype is independently associated with atherosclerosis in T1D individuals aged ≥ 48 years, suggesting an age-related increase in the glycation risk. These findings highlight the potential of the GMI/HbA1c ratio for cardiovascular risk stratification in this population.

Keywords: Carotid atherosclerosis; Glucose Management Indicator; Hemoglobin glycation; Type 1 diabetes.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The study protocol was conducted according to the principles of the Declaration of Helsinki and approved by hospital Research Ethics Committee (HCB/2017/0977 and HCB/2022/0473). All the participants signed written informed consent forms. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Distribution of patients by difference and absolute difference between GMI and HbA1c values (%). A: The figure illustrates the distribution of patients based on the difference between their 14-day GMI and HbA1c levels. The x-axis represents the difference between GMI and HbA1c. The y-axis shows the percentage of patients in the overall cohort within each difference category. Bars on the left represent patients with HbA1c values greater than GMI (HbA1c > GMI), while bars on the right represent those with GMI values greater than HbA1c (GMI > HbA1c). Patients with the same HbA1c and GMI values have been excluded. B: The graph is a visual representation of the distribution of patients based on the absolute difference between GMI and HbA1c values (%). GMI: Glucose Management Indicator. HbA1c: glycated hemoglobin
Fig. 2
Fig. 2
Probability of plaque presence according to GMI/HbA1c ratio and stratifying for age. Model was adjusted for center, gender, LDL- and HDL-cholesterol, BMI, systolic BP, statin treatment, smoking status, duration of diabetes, type of insulin treatment, CGM system, and the presence of microvascular complications (retinopathy and DKD). Dark line: mean probability; Grey area: 95% confidential interval. BMI: Body Mass Index. BP: Blood Pressure. CGM: Continuous Glucose Monitoring. DKD: Diabetic Kidney Disease. GMI: Glucose Management Indicator. HbA1c: glycated hemoglobin. HDL: High Density Lipoprotein. LDL: Low Density Lipoprotein

References

    1. Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC). Study Research Group- Intensive Diabetes Treatment and Cardiovascular outcomes in Type 1 diabetes: the DCCT/EDIC Study 30-Year follow-up. Diabetes Care. 2016;39(5):686–93. - PMC - PubMed
    1. Lind M, Svensson AM, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371(21):1972–82. - PubMed
    1. Nathan DM, Turgeon H, Regan S. Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia. 2007;50(11):2239–44. - PMC - PubMed
    1. Nathan DM, Cleary PA, Backlund J-YC, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53. - PMC - PubMed
    1. Bergenstal RM, Beck WY, Close KL, et al. Glucose Management Indicator (GMI): a New term for estimating A1C from continuous glucose monitoring. Diabetes Care. 2018;41:2275–80. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources